Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein.
作者信息
Walls Alexandra C, Park Young-Jun, Tortorici M Alejandra, Wall Abigail, McGuire Andrew T, Veesler David
出版信息
Cell. 2020 Dec 10;183(6):1735. doi: 10.1016/j.cell.2020.11.032.
Abstract
摘要
相似文献
1
Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein.严重急性呼吸综合征冠状病毒2刺突糖蛋白的结构、功能及抗原性
Cell. 2020 Dec 10;183(6):1735. doi: 10.1016/j.cell.2020.11.032.
2
A Novel Synonymous Mutation of SARS-CoV-2: Is This Possible to Affect Their Antigenicity and Immunogenicity?一种新型的严重急性呼吸综合征冠状病毒2（SARS-CoV-2）同义突变：这有可能影响其抗原性和免疫原性吗？
Vaccines (Basel). 2020 May 14;8(2):220. doi: 10.3390/vaccines8020220.
3
Structural basis of severe acute respiratory syndrome coronavirus 2 infection.严重急性呼吸综合征冠状病毒 2 感染的结构基础。
Curr Opin HIV AIDS. 2021 Jan;16(1):74-81. doi: 10.1097/COH.0000000000000658.
4
Optimized Pseudotyping Conditions for the SARS-COV-2 Spike Glycoprotein.SARS-COV-2 刺突糖蛋白的优化假型条件。
J Virol. 2020 Oct 14;94(21). doi: 10.1128/JVI.01062-20.
5
Nicotinic Cholinergic System and COVID-19: In Silico Identification of an Interaction between SARS-CoV-2 and Nicotinic Receptors with Potential Therapeutic Targeting Implications.烟碱型乙酰胆碱能系统与 COVID-19：SARS-CoV-2 与烟碱受体相互作用的计算鉴定及其潜在治疗靶点意义。
Int J Mol Sci. 2020 Aug 13;21(16):5807. doi: 10.3390/ijms21165807.
6
Targeting the SARS-CoV-2 spike glycoprotein prefusion conformation: virtual screening and molecular dynamics simulations applied to the identification of potential fusion inhibitors.针对 SARS-CoV-2 刺突糖蛋白预融合构象：虚拟筛选和分子动力学模拟在识别潜在融合抑制剂中的应用。
Virus Res. 2020 Sep;286:198068. doi: 10.1016/j.virusres.2020.198068. Epub 2020 Jun 18.
7
Structural, glycosylation and antigenic variation between 2019 novel coronavirus (2019-nCoV) and SARS coronavirus (SARS-CoV).2019新型冠状病毒（2019-nCoV）与严重急性呼吸综合征冠状病毒（SARS-CoV）之间的结构、糖基化及抗原变异
Virusdisease. 2020 Mar;31(1):13-21. doi: 10.1007/s13337-020-00571-5. Epub 2020 Mar 5.
8
Mutations in SARS-CoV-2 Leading to Antigenic Variations in Spike Protein: A Challenge in Vaccine Development.导致新冠病毒刺突蛋白抗原变异的突变：疫苗研发中的一项挑战
J Lab Physicians. 2020 Aug;12(2):154-160. doi: 10.1055/s-0040-1715790. Epub 2020 Sep 1.
9
In silico studies on the comparative characterization of the interactions of SARS-CoV-2 spike glycoprotein with ACE-2 receptor homologs and human TLRs.基于 SARS-CoV-2 刺突糖蛋白与 ACE-2 受体同源物和人类 TLR 相互作用的比较特征的计算机研究。
J Med Virol. 2020 Oct;92(10):2105-2113. doi: 10.1002/jmv.25987. Epub 2020 May 17.
10
SARS-CoV-2: Structural diversity, phylogeny, and potential animal host identification of spike glycoprotein.SARS-CoV-2：刺突糖蛋白的结构多样性、系统发育和潜在动物宿主鉴定。
J Med Virol. 2020 Sep;92(9):1690-1694. doi: 10.1002/jmv.25976. Epub 2020 May 17.
引用本文的文献
1
Host cell and viral protease targets of human SERPINs identified by in silico docking.通过计算机对接鉴定的人丝氨酸蛋白酶抑制剂（SERPINs）的宿主细胞和病毒蛋白酶靶点。
EMBO J. 2025 Sep 8. doi: 10.1038/s44318-025-00546-6.
2
Anticoronavirus Activity of Uridine Glycoconjugates Containing a 1,2,3-Triazole Moiety.含1,2,3-三唑部分的尿苷糖缀合物的抗冠状病毒活性
J Med Chem. 2025 Aug 28;68(16):17859-17873. doi: 10.1021/acs.jmedchem.5c01602. Epub 2025 Aug 8.
3
Exploring the Intrinsic Structural Plasticity and Conformational Dynamics of Human Beta Coronavirus Spike Glycoproteins.探索人类β冠状病毒刺突糖蛋白的内在结构可塑性和构象动力学。
J Chem Inf Model. 2025 Jul 28;65(14):7712-7733. doi: 10.1021/acs.jcim.5c00990. Epub 2025 Jul 17.
4
SARS-CoV-2 in Asthmatic Children: Same Consequences in Different Endotypes?哮喘儿童感染严重急性呼吸综合征冠状病毒2：不同内型会有相同后果吗？
Metabolites. 2025 Jun 16;15(6):406. doi: 10.3390/metabo15060406.
5
Insights into biological therapeutic strategies for COVID-19.对新冠病毒病生物治疗策略的见解
Fundam Res. 2021 Mar;1(2):166-178. doi: 10.1016/j.fmre.2021.02.001. Epub 2021 Feb 4.
6
Unveiling the structural spectrum of SARS-CoV-2 fusion by in situ cryo-ET.通过原位冷冻电子断层扫描揭示严重急性呼吸综合征冠状病毒2（SARS-CoV-2）融合的结构谱。
Nat Commun. 2025 Jun 3;16(1):5150. doi: 10.1038/s41467-025-60406-z.
7
Receptor Binding for the Entry Mechanisms of SARS-CoV-2: Insights from the Original Strain and Emerging Variants.严重急性呼吸综合征冠状病毒2（SARS-CoV-2）进入机制的受体结合：来自原始毒株和新出现变体的见解
Viruses. 2025 May 10;17(5):691. doi: 10.3390/v17050691.
8
Impact of SARS-CoV-2 RBM Mutations N501Y and E484K on ACE2 Binding: A Combined Computational and Experimental Study.严重急性呼吸综合征冠状病毒2（SARS-CoV-2）受体结合基序（RBM）突变N501Y和E484K对血管紧张素转换酶2（ACE2）结合的影响：一项计算与实验相结合的研究
Int J Mol Sci. 2025 Apr 25;26(9):4064. doi: 10.3390/ijms26094064.
9
Intersecting SARS-CoV-2 spike mutations and global vaccine efficacy against COVID-19.严重急性呼吸综合征冠状病毒2（SARS-CoV-2）刺突蛋白突变与全球新冠疫苗有效性的交叉分析
Front Immunol. 2025 Mar 7;16:1435873. doi: 10.3389/fimmu.2025.1435873. eCollection 2025.
10
SARS-related coronavirus S-protein structures reveal synergistic RBM interactions underpinning high-affinity human ACE2 binding.严重急性呼吸综合征相关冠状病毒S蛋白结构揭示了支撑高亲和力人类血管紧张素转换酶2结合的协同受体结合基序相互作用。
Sci Adv. 2025 Mar 14;11(11):eadr8772. doi: 10.1126/sciadv.adr8772.
Zotero 插件